Fair enough, thanks for the criticism. Here a few more studies: https://nutritionandmetabolism.biomedcentral.com/articles/10.1186/1743-7075-2-34 https://nutrit

Fair enough, thanks for the criticism. Here a few more studies: https://nutritionandmetabolism.biomedcentral.com/articles/10.1186/1743-7075-2-34 https://nutritionandmetabolism.biomedcentral.com/articles/10... > The LCKD improved glycemic control in patients with type 2 diabetes such that diabetes medications were discontinued or reduced in most participants. https://pubmed.ncbi.nlm.nih.gov/22673594/ https://pubmed.ncbi.nlm.nih.gov/22673594/ > The LCD and LCKD had beneficial effects on all the parameters examined. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024764/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024764/ > LCD can improve blood glucose more than LFD in Chinese patients with T2DM. It can also regulate blood lipid, reduce BMI, and decrease insulin dose in patients with T2DM. https://pubmed.ncbi.nlm.nih.gov/34338787/ https://pubmed.ncbi.nlm.nih.gov/34338787/ > The VLCK diet appears to control glycemia and decrease body weight for up to 6 months in people with obesity and diabetes. Beneficial changes in serum triglycerides and high-density lipoprotein cholesterol, along with reductions in antidiabetic medications, continued in the VLCK group until 12 months. However, the quality of currently available evidence is not sufficient to recommend VLCK diets. A major limitation of the VLCK diet is patients' lack of adherence to carbohydrate restriction. So sure, there are issues with adherence and the volume & quality of data here. That doesn't invalidate the trends seen across every study that looks into this. It's more than one study and, within each study, it indeed seems to benefit most participants.